Differences in bacterial taxa between treatment-naive patients with major depressive disorder and non-affected controls may be related to a proinflammatory profile
Abstract Background Major depressive disorder (MDD) is characterized by sadness and anhedonia, but also physical symptoms such as changes in appetite and weight. Gut microbiota has been hypothesized to be involved in MDD through gut-brain axis signaling. Moreover, antidepressants display antibacteri...
Main Authors: | Julie Kristine Knudsen, Caspar Bundgaard-Nielsen, Peter Leutscher, Simon Hjerrild, René Ernst Nielsen, Suzette Sørensen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-024-05547-z |
Similar Items
-
Gut microbiota variations in patients diagnosed with major depressive disorder—A systematic review
by: Julie Kristine Knudsen, et al.
Published: (2021-07-01) -
Gut microbiota profiles of autism spectrum disorder and attention deficit/hyperactivity disorder: A systematic literature review.
by: Caspar Bundgaard-Nielsen, et al.
Published: (2020-09-01) -
Faecal microbiota transplantation from patients with depression or healthy individuals into rats modulates mood-related behaviour
by: Julie Kristine Knudsen, et al.
Published: (2021-11-01) -
Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder
by: Rachael Horne, et al.
Published: (2018-10-01) -
The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
by: Sauliha R. Alli, et al.
Published: (2022-04-01)